Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib
MILLER, Vincent A, RIELY, Gregory J, HERBST, Roy S, HELLER, Glenn, LADANYI, Marc, PAO, William, JOHNSON, David H, ZAKOWSKI, Maureen F, LI, Allan R, PATEL, Jyoti D, HEELAN, Robert T, KRIS, Mark G, SANDIER, Alan B, CARBONE, David P, TSAO, Anne
Published in Journal of clinical oncology (20.03.2008)
Published in Journal of clinical oncology (20.03.2008)
Get full text
Journal Article
Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
HEYMACH, John V, PAZ-ARES, Luis, BONOMI, Philip D, HERBST, Roy S, KREBS, Annetta D, VASSELLI, James, JOHNSON, Bruce E, DE BRAUD, Filippo, SEBASTIAN, Martin, STEWART, David J, EBERHARDT, Wilfried E. E, RANADE, Anantbhushan A, COHEN, Graham, TRIGO, Jose Manuel, SANDIER, Alan B
Published in Journal of clinical oncology (20.11.2008)
Published in Journal of clinical oncology (20.11.2008)
Get full text
Journal Article
Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy
VANSTEENKISTE, Johan, LARA, Primo N, PECK, Ronald, EDELMAN, Mark, LE CHEVALIER, Thierry, BRETON, Jean-Luc, BONOMI, Philip, SANDIER, Alan B, SOCINSKI, Mark A, DELBALDO, Catherine, MCHENRY, Brent, LEBWOHL, David
Published in Journal of clinical oncology (10.08.2007)
Published in Journal of clinical oncology (10.08.2007)
Get full text
Journal Article
Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program
DILTS, David M, SANDIER, Alan B, CHENG, Steven K, CRITES, Joshua S, FERRANTI, Lori B, WU, Amy Y, FINNIGAN, Shanda, FRIEDMAN, Steven, MOONEY, Margaret, ABRAMS, Jeffrey
Published in Journal of clinical oncology (10.04.2009)
Published in Journal of clinical oncology (10.04.2009)
Get full text
Journal Article
Processes to Activate Phase III Clinical Trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B
DILTS, David M, SANDIER, Alan B, SCOGGINS, Maren, WU, Amy, KAI ZHOU, SCHILSKY, Richard L, BAKER, Matthew, CHENG, Steven K, GEORGE, Stephen L, KARAS, Kathleen S, MCGUIRE, Stephen, MENON, Gourija S, REUSCH, Jason, SAWYER, Debbie
Published in Journal of clinical oncology (01.10.2006)
Published in Journal of clinical oncology (01.10.2006)
Get full text
Journal Article
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors
KOBAYASHI, Hiroyuki, GAIL ECKHARDT, S, WOLIN, Maurice, BASCHE, Michele L, LOCKRIDGE, Jennifer A, ROTHENBERG, Mace L, SANDIER, Alan B, O'BRYANT, Cindy L, COOPER, Wendy, HOLDEN, Scott N, AITCHISON, Roger D, USMAN, Nassim
Published in Cancer chemotherapy and pharmacology (01.10.2005)
Published in Cancer chemotherapy and pharmacology (01.10.2005)
Get full text
Journal Article
Role of computed tomography in the staging of primary melanoma
Buzaid, A C, Sandler, A B, Mani, S, Curtis, A M, Poo, W J, Bolognia, J L, Ariyan, S
Published in Journal of clinical oncology (01.04.1993)
Published in Journal of clinical oncology (01.04.1993)
Get more information
Journal Article
Neuron-specific enolase as a tumor marker in metastatic melanoma
Buzaid, A C, Sandler, A B, Hayden, C L, Scinto, J, Poo, W J, Clark, M B, Hotchkiss, S
Published in American journal of clinical oncology (01.10.1994)
Published in American journal of clinical oncology (01.10.1994)
Get more information
Journal Article